Here is My Question:
I am being switched from Rituximab to Truxima for my next (3rd) infusion. I am worried about a change and if Truxima has been tested at all on MS?
Truxima is a biosimilar rituximab that was reviewed by the FDA. It's labeling is Truxima (rituximab monoclonal antibodies). Rituximab was tested in phase 2 clinical trials for MS and was found to be effective. There is no material difference between Truxima and Rituxan (the original brand name of rituximab).
A. Scott Nielsen MD MMSc
Neurologist and MS Specialist at Kaiser Permanente
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.